Cancer Communications Q1
Unclaimed
John Wiley & Sons Inc.
United Kingdom
Cancer Communications is a journal indexed in SJR in Oncology and Cancer Research with an H index of 79. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 4,95 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,95.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -




Categories:
Cancer Research (Q1)
Oncology (Q1)
Price
1507 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
4,95
SJR Impact factor79
H Index108
Total Docs (Last Year)289
Total Docs (3 years)4873
Total Refs3552
Total Cites (3 years)176
Citable Docs (3 years)12.39
Cites/Doc (2 years)45.12
Ref/DocOther journals with similar parameters
Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1
Compare this journals
Aims and Scope
Cancer
Comments